JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EU
5126
enCore Energy
EU
$198M
| $275K | ﹤0.01% |
80,781
-392
| -0.5% | -$1.48K |
2023 Q2
6 quarters
|
|
|
CRGX
5127
DELISTED
CARGO Therapeutics
CRGX
| $275K | ﹤0.01% |
19,066
+4,059
| +27% | +$73.7K |
2024 Q1
3 quarters
|
|
5128
U.S. Core Equity 1 Portfolio ETF Class Shares
DCOR
$3.55B
| $274K | ﹤0.01% |
4,276
+7
| +0.2% | +$456 |
2023 Q4
4 quarters
|
|
5129
LifeMD
LFMD
$132M
| $273K | ﹤0.01% |
55,204
-32,969
| -37% | -$173K |
2024 Q2
2 quarters
|
|
5130
CALL
Emerson Electric
EMR
$90.1B
| $273K | ﹤0.01% |
2,200
| – | – |
2021 Q1
15 quarters
|
|
5131
American Coastal Insurance
ACIC
$441M
| $272K | ﹤0.01% |
20,228
+3,524
| +21% | +$44K |
2017 Q2
30 quarters
|
|
5132
Oric Pharmaceuticals
ORIC
$1.27B
| $272K | ﹤0.01% |
33,736
-1,515
| -4% | -$13.9K |
2020 Q2
18 quarters
|
|
|
OLPX
5133
DELISTED
Olaplex Holdings
OLPX
| $271K | ﹤0.01% |
156,563
+94,531
| +152% | +$188K |
2021 Q3
13 quarters
|
|
5134
Lifetime Brands
LCUT
$210M
| $269K | ﹤0.01% |
45,589
+40,188
| +744% | +$242K |
2013 Q2
46 quarters
|
|
5135
Inspired Entertainment
INSE
$91.2M
| $269K | ﹤0.01% |
29,742
+19,928
| +203% | +$189K |
2019 Q2
22 quarters
|
|
5136
Aquestive Therapeutics
AQST
$571M
| $269K | ﹤0.01% |
75,500
+30,467
| +68% | +$140K |
2018 Q3
25 quarters
|
|
|
AOMR
5137
Angel Oak Mortgage REIT
AOMR
$170M
| $268K | ﹤0.01% |
28,931
+1,730
| +6% | +$16.6K |
2021 Q3
13 quarters
|
|
5138
First Trust Utilities AlphaDEX Fund
FXU
$732M
| $268K | ﹤0.01% |
7,090
+1,422
| +25% | +$55.1K |
2023 Q3
5 quarters
|
|
5139
TriplePoint Venture Growth BDC
TPVG
$199M
| $267K | ﹤0.01% |
36,241
+33,941
| +1,476% | +$250K |
2017 Q1
31 quarters
|
|
5140
PUT
FMC
FMC
$1.31B
| $267K | ﹤0.01% |
5,500
+5,400
| +5,400% | +$315K |
2024 Q2
2 quarters
|
|
5141
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$246M
| $267K | ﹤0.01% |
2,094
+1,393
| +199% | +$182K |
2023 Q4
4 quarters
|
|
5142
Foghorn Therapeutics
FHTX
$120M
| $267K | ﹤0.01% |
56,531
+45,565
| +416% | +$332K |
2020 Q4
16 quarters
|
|
5143
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.29B
| $266K | ﹤0.01% |
12,435
-1,051
| -8% | -$23.2K |
2013 Q2
46 quarters
|
|
|
OPI
5144
DELISTED
Office Properties Income Trust
OPI
| $266K | ﹤0.01% |
265,825
-348,740
| -57% | -$538K |
2019 Q1
23 quarters
|
|
5145
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$2.93B
| $265K | ﹤0.01% |
6,172
-57,024
| -90% | -$2.5M |
2021 Q1
15 quarters
|
|
5146
1-800-Flowers.com
FLWS
$164M
| $265K | ﹤0.01% |
32,388
+18,293
| +130% | +$147K |
2017 Q4
28 quarters
|
|
5147
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
$768M
| $264K | ﹤0.01% |
12,200
+2,606
| +27% | +$57.3K |
2024 Q2
2 quarters
|
|
5148
Dianthus Therapeutics
DNTH
$4.93B
| $264K | ﹤0.01% |
12,129
+1,490
| +14% | +$38.3K |
2018 Q3
25 quarters
|
|
5149
United States Oil Fund
USO
$1.98B
| $264K | ﹤0.01% |
3,494
-38,412
| -92% | -$2.81M |
2023 Q3
5 quarters
|
|
5150
Metagenomi Therapeutics
MGX
$38.5M
| $264K | ﹤0.01% |
73,031
+65,020
| +812% | +$157K |
2024 Q1
3 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.